Literature DB >> 5259767

Uroporphyrinogen 3 cosynthetase in human congenital erythropoietic porphyria.

G Romeo, E Y Levin.   

Abstract

Activity of the enzyme uroporphyrinogen III cosynthetase in hemolysates from five patients with congenital erythropoietic porphyria was much lower than the activity in control samples. The low cosynthetase activity in patients was not due to the presence of a free inhibitor or some competing enzymatic activity, because hemolysates from porphyric subjects did not interfere either with the cosynthetase activity of hemolysates from normal subjects or with cosynthetase prepared from hematopoietic mouse spleen. This partial deficiency of cosynthetase in congenital erythropoietic porphyria corresponds to that shown previously in the clinically similar erythropoietic porphyria of cattle and explains the overproduction of uroporphyrin I in the human disease.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5259767      PMCID: PMC223531          DOI: 10.1073/pnas.63.3.856

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  A SUGGESTED CONTROL GENE MECHANISM FOR THE EXCESSIVE PRODUCTION OF TYPES I AND 3 PORPHYRINS IN CONGENITAL ERYTHROPOIETIC PORPHYRIA.

Authors:  C J WATSON; W RUNGE; L TADDEINI; I BOSSENMAIER; R CARDINAL
Journal:  Proc Natl Acad Sci U S A       Date:  1964-08       Impact factor: 11.205

2.  A qualitative and quantitative study of the separation of uroporphyrin octamethyl esters I and III by dioxan chromatography.

Authors:  P A CORNFORD; A BENSON
Journal:  J Chromatogr       Date:  1963-02

3.  Studies on the biosynthesis of uroporphyrin III from porphobilinogen and the behaviour of uroporphyrin esters in paper chromatography.

Authors:  L BOGORAD; G S MARKS
Journal:  Biochim Biophys Acta       Date:  1960-07-01

4.  The enzymatic synthesis of porphyrins from porphobilinogen. I. Uroporphyrin I.

Authors:  L BOGORAD
Journal:  J Biol Chem       Date:  1958-08       Impact factor: 5.157

5.  The enzymatic synthesis of porphyrins from porphobilinogen. II. Uroporphyrin III.

Authors:  L BOGORAD
Journal:  J Biol Chem       Date:  1958-08       Impact factor: 5.157

6.  Porphyrin content of bone marrow and liver in the various forms of porphyria.

Authors:  R SCHMID; S SCHWARTZ; C J WATSON
Journal:  AMA Arch Intern Med       Date:  1954-02

7.  Congenital erythropoietic porphyria. I. Case report, special studies and therapy.

Authors:  R G Haining; M L Cowger; D B Shurtleff; R F Labbe
Journal:  Am J Med       Date:  1968-10       Impact factor: 4.965

8.  Uroporphyrinogen 3 cosynthetase from mouse spleen.

Authors:  E Y Levin
Journal:  Biochemistry       Date:  1968-11       Impact factor: 3.162

9.  Studies of the uroporphyrins. III. An improved method for the decarboxylation of uroporphyrin.

Authors:  P R EDMONDSON; S SCHWARTZ
Journal:  J Biol Chem       Date:  1953-12       Impact factor: 5.157

10.  Uroporphyrinogen 3 cosynthetase in bovine erythropoietic porphyria.

Authors:  E Y Levin
Journal:  Science       Date:  1968-08-30       Impact factor: 47.728

View more
  24 in total

1.  A novel point mutation in congenital erythropoietic porphyria in two members of Japanese family.

Authors:  K Tanigawa; M Bensidhoum; N Takamura; H Namba; S Yamashita; H de Verneuil; C Ged
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

2.  Congenital erythropoietic porphyria and congenital adrenal hyperplasia with evidence for hepatic delta-5 alpha-reductase deficiency.

Authors:  J A Miller; G M Levene
Journal:  J R Soc Med       Date:  1989-02       Impact factor: 5.344

3.  Uroporphyrinogen 3 cosynthetase activity in fibroblasts from patients with congenital erythropoietic porphyria.

Authors:  G Romeo; M M Kaback; E Y Levin
Journal:  Biochem Genet       Date:  1970-12       Impact factor: 1.890

4.  Uroporphyrinogen 3 cosynthetase in asymptomatic carriers of congenital erythpoietic porphyria.

Authors:  G Romeo; B L Glenn; E Y Levin
Journal:  Biochem Genet       Date:  1970-12       Impact factor: 1.890

5.  Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria.

Authors:  F Mazurier; F Moreau-Gaudry; S Salesse; C Barbot; C Ged; J Reiffers; H de Verneuil
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 6.  Porphyrias: animal models and prospects for cellular and gene therapy.

Authors:  H de Verneuil; C Ged; S Boulechfar; F Moreau-Gaudry
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

7.  Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.

Authors:  David F Bishop; Annika Johansson; Robert Phelps; Amr A Shady; Maria C M Ramirez; Makiko Yasuda; Andres Caro; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2006-02-09       Impact factor: 11.025

8.  Erythropoietic porphyria of the fox squirrel Sciurus niger.

Authors:  E Y Levin; V Flyger
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

9.  Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria.

Authors:  C J Watson; I Bossenmaier; R Cardinal; Z J Petryka
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

Review 10.  Enzymatic defects of hereditary porphyrias: an explanation of dominance at the molecular level.

Authors:  G Romeo
Journal:  Hum Genet       Date:  1977-12-23       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.